Evidence map›Paper›PMID 42187583›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods Study.

Andreia F Moura, Catarina S Padilla, Samuel M Vorbach, Emily I Holthuis, Baukelien van Triest, Cristiane D Bergerot, Vassilios Vassiliou, Emir Celik, Kübra Akkaya, Irfan Cicin and 4 more

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Andreia F MouraQuality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, 1200 Brussels, Belgium.ORCID 0000-0002-1797-6486
Catarina S PadillaDepartment of Medical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0003-1821-3760
Samuel M VorbachDepartment of Radiation Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0009-0003-1711-1604
Emily I HolthuisDepartment of Medical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0002-2556-4553
Baukelien van TriestDepartment of Radiation Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Cristiane D BergerotDepartment of Supportive Care, Oncoclinicas&Co-Medica Scientia Innovation Research (MEDSIR), Sao Paulo 13571-410, SP, Brazil.
Vassilios VassiliouDepartment of Radiation Oncology, Bank of Cyprus Oncology Centre, Nicosia 2006, Cyprus.ORCID 0000-0003-0659-6848
Emir CelikDepartment of Medical Oncology, Faculty of Medicine, Istinye University, Istanbul 34396, Turkey.
Kübra AkkayaDepartment of Medical Oncology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul 34000, Turkey.ORCID 0000-0001-5851-0239
Irfan CicinDepartment of Medical Oncology, Faculty of Medicine, Istinye University, Istanbul 34396, Turkey.ORCID 0000-0002-7584-3868
Winette T A van der GraafDepartment of Medical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0001-7549-3338
Olga HussonDepartment of Medical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0002-1387-8686
Samantha C SodergrenSchool of Health Sciences, University of Southampton, Southamptom SO17 1BJ, UK.ORCID 0000-0001-8755-146X
EORTC Quality of Life Group

Funding

The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) 003-2022
6 · The paper itself

Abstract

Anal cancer is a rare and under-researched malignancy, leading to limited understanding of patients' experiences and potentially insufficiently tailored care. This study explored the health-related quality of life (HRQoL) and healthcare interactions of people with anal cancer. Patients with confirmed diagnosis took part in semi-structured interviews, supplemented by two European Organisation for Research and Treatment of Cancer (EORTC) HRQoL questionnaires. Data were analysed using Interpretative Phenomenological Analysis and organized into themes. Twenty-one patients (71% female; mean age of 62 years) from five countries were included. HRQoL challenges were identified across four phases: illness onset, diagnosis, treatment, and life beyond treatment. Key themes included misdiagnosis, not being taken seriously, and emotional and social disruptions. Additional themes involved stigma, embarrassment, strain on loved ones, and healthcare experiences. Defecation problems were especially burdensome, beginning at onset, intensifying during treatment, and persisting as a chronic issue affecting well-being. Patients described coping strategies and sometimes reframed their experiences positively, expressing gratitude for support received. Questionnaire findings aligned with patients' reports of prominent physical symptoms. Anal cancer remains highly stigmatized, creating complex physical, emotional, and social challenges. Individualized care and extended psychosocial and practical support beyond treatment are essential to improve HRQoL and dignity in survivorship.

Indexed as

Anus NeoplasmsQuality of LifeAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedSurveys and Questionnairesanal cancerEORTChealthcare experiencehealth-related quality of lifemixed-methodsqualitative interviewsrare cancers

Identifiers

PMID42187583
PMCPMC13204992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.